Cardiol Therapeutics Management
Management criteria checks 1/4
Cardiol Therapeutics' CEO is David Elsley, appointed in Jan 2017, has a tenure of 7.33 years. total yearly compensation is CA$748.10K, comprised of 70.2% salary and 29.8% bonuses, including company stock and options. directly owns 1.69% of the company’s shares, worth CA$3.28M. The average tenure of the management team and the board of directors is 4.6 years and 2.3 years respectively.
Key information
David Elsley
Chief executive officer
CA$748.1k
Total compensation
| CEO salary percentage | 70.2% |
| CEO tenure | 7.3yrs |
| CEO ownership | 1.7% |
| Management average tenure | 4.6yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?
May 01
Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?
Jan 06Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?
Sep 13We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
May 24We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Jan 20We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Aug 10We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn
Apr 17Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Dec 09We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
Aug 19Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Apr 18Companies Like Cardiol Therapeutics (TSE:CRDL) Are In A Position To Invest In Growth
Jan 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CA$748k | CA$525k | -CA$28m |
| Sep 30 2023 | n/a | n/a | -CA$28m |
| Jun 30 2023 | n/a | n/a | -CA$30m |
| Mar 31 2023 | n/a | n/a | -CA$29m |
| Dec 31 2022 | CA$654k | CA$525k | -CA$31m |
| Sep 30 2022 | n/a | n/a | -CA$30m |
| Jun 30 2022 | n/a | n/a | -CA$32m |
| Mar 31 2022 | n/a | n/a | -CA$32m |
| Dec 31 2021 | CA$1m | CA$455k | -CA$32m |
| Sep 30 2021 | n/a | n/a | -CA$35m |
| Jun 30 2021 | n/a | n/a | -CA$30m |
| Mar 31 2021 | n/a | n/a | -CA$27m |
| Dec 31 2020 | CA$517k | CA$450k | -CA$21m |
| Sep 30 2020 | n/a | n/a | -CA$14m |
| Jun 30 2020 | n/a | n/a | -CA$13m |
| Mar 31 2020 | n/a | n/a | -CA$13m |
| Dec 31 2019 | CA$450k | CA$450k | -CA$14m |
| Sep 30 2019 | n/a | n/a | -CA$20m |
| Jun 30 2019 | n/a | n/a | -CA$21m |
| Mar 31 2019 | n/a | n/a | -CA$19m |
| Dec 31 2018 | CA$713k | CA$363k | -CA$16m |
Compensation vs Market: David's total compensation ($USD546.98K) is above average for companies of similar size in the Canadian market ($USD174.43K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Elsley
7.3yrs
Tenure
CA$748,100
Compensation
Mr. David G. Elsley, MBA, has been the President, Chief Executive Officer and Director of Cardiol Therapeutics Inc since January 19, 2017. Mr. Elsley is a business leader with a proven track record of deve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.3yrs | CA$748.10k | 1.69% CA$ 3.3m | |
| CFO, Corporate Secretary & Director | 5.8yrs | CA$294.80k | 0.16% CA$ 312.4k | |
| Chief Operating Officer | 3.4yrs | CA$515.90k | 0.044% CA$ 85.2k | |
| Chief Medical Officer & Head of Research & Development | 3.2yrs | CA$746.56k | 0.35% CA$ 679.8k | |
| Investor Relations | no data | no data | no data |
4.6yrs
Average Tenure
Experienced Management: CRDL's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.3yrs | CA$748.10k | 1.69% CA$ 3.3m | |
| CFO, Corporate Secretary & Director | 2yrs | CA$294.80k | 0.16% CA$ 312.4k | |
| Independent Director | 4.4yrs | CA$60.00k | 0.21% CA$ 404.7k | |
| Independent Director | 2.2yrs | CA$76.92k | 0% CA$ 0 | |
| Independent Director | 6.4yrs | CA$58.00k | 0.68% CA$ 1.3m | |
| Independent Director | 2.7yrs | CA$71.52k | 1.13% CA$ 2.2m | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 2yrs | CA$82.32k | 0.088% CA$ 170.4k | |
| Independent Chairman | 5.8yrs | CA$112.68k | 0.13% CA$ 253.2k | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
55yo
Average Age
Experienced Board: CRDL's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.